Concepedia

Michelle Mott

MM

Statistics

Publications

9

Citations

784

H-Index

9

Active since

1998

Affiliations

City of Hope(Current)

Cornell University

City Of Hope National Medical Center

Emory University

Michelle Mott is an author at City of Hope specializing in medicine, hematology, and immunotherapy.

Publications per year

1998–2025

9

Publications

9

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Xiuli Wang, Leslie Popplewell, Jamie R. Wagner et al. · Blood · 2016 · 330 citations · Full text

Life Sciences, Hematology, Immunology +14

Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Robert Chen, Joycelynne Palmer, Peter Martin et al. · Biology of Blood and Marrow Transplantation · 2015 · 152 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Phase I study of temozolomide in paediatric patients with advanced cancer

EJ Estlin, L. S. Lashford, S Ablett et al. · British Journal of Cancer · 1998 · 139 citations · Full text

Medicine, Oncology, Pharmacology +10

A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma

Robert Chen, Paul Frankel, Leslie Popplewell et al. · Haematologica · 2015 · 72 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Phase I study of nelfinavir in liposarcoma

Janet Pan, Michelle Mott, Bixin Xi et al. · Cancer Chemotherapy and Pharmacology · 2012 · 34 citations · Full text

Medicine, Oncology, Pharmacology +7

1–5 of 9